Actual Medicinal Product (AMP) Adartrel 500microgram tablets (GlaxoSmithKline UK Ltd)
Stability Information
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light. Store in original package.
- Generic
- Ropinirole
- Formulation
- Ropinirole 500microgram tablets
-
Ropinirole
-
Ropinirole 500microgram tablets
-
Adartrel 500microgram tablets (GlaxoSmithKline UK Ltd)
-
-
Adartrel 500microgram tablets (Sigma Pharmaceuticals Plc)
Ropinirole 500microgram tablets (Viatris UK Healthcare Ltd)